Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
5.53
-0.16 (-2.81%)
At close: Mar 5, 2026, 4:00 PM EST
5.55
+0.02 (0.36%)
After-hours: Mar 5, 2026, 7:55 PM EST
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $983.58 million as of March 5, 2026. Its market cap has increased by 125.51% in one year.
Market Cap
983.58M
Enterprise Value
784.50M
1-Year Change
125.51%
Ranking
Category
Stock Price
$5.53
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has increased from $435.34M to $983.58M, an increase of 125.93%. That is a compound annual growth rate of 18.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 1.01B | 5.96% |
| Dec 31, 2025 | 955.12M | 378.75% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibrx Biosciences | 1.09B |
| Xeris Biopharma Holdings | 1.05B |
| Sana Biotechnology | 1.02B |
| Ventyx Biosciences | 1.00B |
| GH Research | 991.85M |
| Maravai LifeSciences Holdings | 982.00M |
| UroGen Pharma | 981.43M |
| Fortrea Holdings | 970.53M |